301130 Jilin Province Xidian Pharmaceutical Sci-Tech Development
- 26.78
- +0.06+0.22%
Jilin Province Xidian Pharmaceutical Sci-Tech Development News
West Point Pharmaceuticals: Notice on Using Some Idle Raised Funds for Cash Management and Idle Own Funds to Redeem Entrusted Wealth Management at maturity and continue to carry out cash management and delegated financial management
West Point Pharmaceuticals: Pre-disclosure Notice on Shareholders Holding 5% or More of Their Shares and Their Coordinating Actions to Reduce Their Shareholding
West Point Pharmaceuticals: Third Quarter Report 2024
Xidian Pharmaceutical: 2024-085 Announcement on the Company\'s approval notice for risperidone oral tablets to obtain a supplementary drug application
West Point Pharmaceuticals: Announcement on share repurchase results and share changes
West Point Pharmaceuticals: Notice on Using Some Idle Raised Funds for Cash Management and Idle Own Funds to Redeem Entrusted Wealth Management at maturity and continue to carry out cash management and delegated financial management
West Point Pharmaceuticals: Progress Announcement on the Repurchase of the Company\'s Shares
West Point Pharmaceuticals: Notice on all shareholders holding 5% or more of their shares being judicially frozen and unfrozen
West Point Pharmaceuticals: Progress Announcement on Repurchase Ratio of Shares Reaching 1%
West Point Pharmaceutical: Progress Announcement on the Use of Some Idle Raised Funds for Cash Management, Expiration, and Continued Cash Management
West Point Pharmaceuticals: Progress Announcement on the Repurchase of the Company\'s Shares
West Point Pharmaceuticals: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024
West Point Pharmaceuticals: Semi-Annual Report 2024
West Point Pharmaceuticals: Summary table on the use of non-operating capital and other related capital transactions for the first half year of 2024
West Point Pharmaceutical: Haitong Securities 2024 Semi-Annual Follow-up Report on West Point Pharmaceutical
West Point Pharmaceuticals: 2024 Semi-Annual Financial Report
West Point Pharmaceuticals: 2024 Semi-Annual Report Summary
Xidian Pharmaceutical: Announcement of Board Resolutions
West Point Pharmaceuticals: Announcement of Supervisory Committee Resolutions
Jilin Province Xidian Pharmaceutical Sci-Tech Development: Announcement on the progress of using a portion of idle raised funds for cash management at maturity redemption and continuing cash management, as well as using a portion of idle self-owned funds for entrusted wealth management.
Analysis
Price Target
No Data
No Data